ERBB2 and diabetes mellitus: Subtypes of breast cancer that carry a poorer prognosis, including PR/HER2-negative breast cancers, TNBC, and the closely related basal-like breast cancer molecular subtype have also been reported to occur at greater frequency in women with diabetes than in those without diabetes (66, 67).